...
首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >Oncostatin M up-regulates tissue inhibitor of metalloproteinases-3 gene expression in articular chondrocytes via de novo transcription, protein synthesis, and tyrosine kinase- and mitogen-activated protein kinase-dependent mechanisms.
【24h】

Oncostatin M up-regulates tissue inhibitor of metalloproteinases-3 gene expression in articular chondrocytes via de novo transcription, protein synthesis, and tyrosine kinase- and mitogen-activated protein kinase-dependent mechanisms.

机译:抑癌素M通过从头转录,蛋白质合成以及酪氨酸激酶和促丝裂原激活的蛋白激酶依赖性机制上调关节软骨细胞中金属蛋白酶3基因表达的组织抑制剂。

获取原文
获取原文并翻译 | 示例
           

摘要

Cytokines and growth factors regulate physiologic and pathologic turn-over of cartilage extracellular matrix (ECM) by altering the balance between tissue inhibitors of metalloproteinases (TIMPs) and matrix metalloproteinases (MMPs). Oncostatin M (OSM) is a cytokine of the IL-6 family whose levels are increased in the serum and synovial fluids of patients with rheumatoid arthritis. We examined responsiveness of the TIMP-3 gene to OSM in articular chondrocytes and studied the regulatory and signaling mechanisms of this response. OSM induced TIMP-3 mRNA and protein expression in a dose- and time-dependent fashion. Concomitantly, stromelysin-1 and collagenase-1 RNA and activities were also induced. A cartilage matrix growth factor, TGF-beta, induced TIMP-3, but combined OSM and TGF-beta did not further increase the extent of induction, suggesting a lack of synergy between the two. OSM induction of TIMP-3 gene expression was dependent upon de novo protein synthesis and transcription. RNA decay time-courses suggested that the OSM-mediated increase of TIMP-3 RNA was not due to enhanced message stability and, along with inhibition by actinomycin-D, suggested a transcriptional control. The antiinflammatory glucocorticoid, dexamethasone, down-regulated this augmentation. Investigation of the signaling mechanisms revealed that protein tyrosine kinase inhibitors genistein and herbimycin A, as well as the specific mitogen-activated protein kinase (MAPK) kinase inhibitor PD98059, suppressed OSM-induced TIMP-3 message expression, suggesting the involvement of tyrosine kinases and mitogen-activated protein kinase cascades in the signaling of OSM leading to TIMP-3 RNA enhancement. Thus OSM can potentially alter the cartilage matrix metabolism by regulating genes like TIMP-3 and matrix metalloproteinases.
机译:细胞因子和生长因子通过改变组织金属蛋白酶(TIMPs)和基质金属蛋白酶(MMPs)之间的平衡来调节软骨细胞外基质(ECM)的生理和病理转换。 Oncostatin M(OSM)是IL-6家族的一种细胞因子,在类风湿性关节炎患者的血清和滑液中水平升高。我们检查了关节软骨细胞中TIMP-3基因对OSM的反应性,并研究了这种反应的调节和信号传导机制。 OSM以剂量和时间依赖性方式诱导TIMP-3 mRNA和蛋白质表达。同时,还诱导了stromelysin-1和胶原酶-1 RNA及其活性。软骨基质生长因子TGF-β诱导了TIMP-3,但OSM和TGF-β的组合并未进一步增加诱导程度,表明两者之间缺乏协同作用。 OSM诱导TIMP-3基因表达取决于从头蛋白质合成和转录。 RNA衰变的时程表明,OSM介导的TIMP-3 RNA的增加不是由于增强的消息稳定性,以及放线菌素D的抑制,提示了转录控制。抗炎糖皮质激素地塞米松下调了这种增强作用。对信号转导机制的研究表明,蛋白质酪氨酸激酶抑制剂染料木黄酮和除草素A以及特定的促分裂原活化蛋白激酶(MAPK)激酶抑制剂PD98059抑制OSM诱导的TIMP-3信息表达,提示酪氨酸激酶和丝裂原激活的蛋白激酶在OSM信号传导中级联,导致TIMP-3 RNA增强。因此,OSM可以通过调节TIMP-3和基质金属蛋白酶等基因来改变软骨基质的代谢。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号